These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33471090)

  • 1. Cardiac Remodeling and Hypertension in HIV-Uninfected Infants Exposed in utero to Antiretroviral Therapy.
    García-Otero L; López M; Goncé A; Fortuny C; Salazar L; Valenzuela-Alcaraz B; Guirado L; César S; Gratacós E; Crispi F
    Clin Infect Dis; 2021 Aug; 73(4):586-593. PubMed ID: 33471090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy.
    Lipshultz SE; Sasaki N; Thompson B; Eidem BW; Cheng I; Colan SD; O'Brien SE; Amdani S; Shearer WT; Orav EJ; Miller TL; Wilkinson JD
    AIDS; 2020 Mar; 34(4):529-537. PubMed ID: 31764073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal cardiovascular remodeling persists at 6 months in infants with intrauterine growth restriction.
    Cruz-Lemini M; Crispi F; Valenzuela-Alcaraz B; Figueras F; Sitges M; Bijnens B; Gratacós E
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):349-56. PubMed ID: 26415719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling.
    García-Otero L; López M; Gómez O; Goncé A; Bennasar M; Martínez JM; Valenzuela-Alcaraz B; Rodriguez-López M; Sitges M; Loncà M; Bijnens B; Crispi F; Gratacós E
    AIDS; 2016 Jun; 30(9):1393-401. PubMed ID: 26919731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of intrauterine exposure to maternal HIV and antiretroviral therapy in Ethiopian infants followed from fetal life.
    García-Otero L; Walles J; Balcha TT; Merga G; López M; Crispi F; Björkman P
    AIDS; 2022 Jun; 36(7):941-951. PubMed ID: 35142707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.
    Guerra V; Leister EC; Williams PL; Starc TJ; Lipshultz SE; Wilkinson JD; Van Dyke RB; Hazra R; Colan SD
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):621-7. PubMed ID: 26794032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assisted reproductive technologies are associated with cardiovascular remodeling in utero that persists postnatally.
    Valenzuela-Alcaraz B; Crispi F; Bijnens B; Cruz-Lemini M; Creus M; Sitges M; Bartrons J; Civico S; Balasch J; Gratacós E
    Circulation; 2013 Sep; 128(13):1442-50. PubMed ID: 23985787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal persistence of fetal cardiovascular remodelling associated with assisted reproductive technologies: a cohort study.
    Valenzuela-Alcaraz B; Serafini A; Sepulveda-Martínez A; Casals G; Rodríguez-López M; Garcia-Otero L; Cruz-Lemini M; Bijnens B; Sitges M; Balasch J; Gratacós E; Crispi F
    BJOG; 2019 Jan; 126(2):291-298. PubMed ID: 29673050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of tenofovir during pregnancy: early growth outcomes and hematologic side effects in HIV-exposed uninfected infants.
    Seidel V; Weizsäcker K; Henrich W; Rancourt RC; Bührer C; Krüger R; Feiterna-Sperling C
    Eur J Pediatr; 2020 Jan; 179(1):99-109. PubMed ID: 31659467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment.
    García-Otero L; López M; Guitart-Mampel M; Morén C; Goncé A; Esteve C; Salazar L; Gómez O; Martínez JM; Torres B; César S; Garrabou G; Crispi F; Gratacós E
    PLoS One; 2019; 14(3):e0213279. PubMed ID: 30830946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).
    Lipshultz SE; Shearer WT; Thompson B; Rich KC; Cheng I; Orav EJ; Kumar S; Pignatelli RH; Bezold LI; LaRussa P; Starc TJ; Glickstein JS; O'Brien S; Cooper ER; Wilkinson JD; Miller TL; Colan SD
    J Am Coll Cardiol; 2011 Jan; 57(1):76-85. PubMed ID: 21185505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.
    M le Roux S; Jao J; Brittain K; Phillips TK; Olatunbosun S; Ronan A; Zerbe A; Abrams EJ; Myer L
    AIDS; 2017 Jan; 31(1):97-104. PubMed ID: 27898591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.